Cargando…

Therapeutical Targets in Allergic Inflammation

From the discovery of IgE to the in-depth characterization of Th2 cells and ILC2, allergic inflammation has been extensively addressed to find potential therapeutical targets. To date, omalizumab, an anti-IgE monoclonal antibody, and dupilumab, an anti-IL-4 receptor α monoclonal antibody, represent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salvati, Lorenzo, Liotta, Francesco, Annunziato, Francesco, Cosmi, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687898/ https://www.ncbi.nlm.nih.gov/pubmed/36359393 http://dx.doi.org/10.3390/biomedicines10112874

Ejemplares similares

From Emollients to Biologicals: Targeting Atopic Dermatitis
por: Salvati, Lorenzo, et al.
Publicado: (2021)

Thymic stromal lymphopoietin and alarmins as possible therapeutical targets for asthma
por: Salvati, Lorenzo, et al.
Publicado: (2021)

Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
por: Mazzoni, Alessio, et al.
Publicado: (2021)

IL-1 and T Helper Immune Responses
por: Santarlasci, Veronica, et al.
Publicado: (2013)

Th17 and Th1 Lymphocytes in Oligoarticular Juvenile Idiopathic Arthritis
por: Maggi, Laura, et al.
Publicado: (2019)

Group 2 Innate Lymphoid Cells: A Double-Edged Sword in Cancer?
por: Maggi, Enrico, et al.
Publicado: (2020)

Pulmonary vascular improvement in severe COVID-19 patients treated with tocilizumab
por: Salvati, Lorenzo, et al.
Publicado: (2020)

Phenotype, Localization, and Mechanism of Suppression of CD4(+)CD25(+) Human Thymocytes
por: Annunziato, Francesco, et al.
Publicado: (2002)

Variants Disrupting CD40L Transmembrane Domain and Atypical X-Linked Hyper-IgM Syndrome: A Case Report With Leishmaniasis and Review of the Literature
por: Palterer, Boaz, et al.
Publicado: (2022)

Heterogeneous magnitude of immunological memory to SARS‐CoV‐2 in recovered individuals
por: Mazzoni, Alessio, et al.
Publicado: (2021)

Innate lymphoid cells type 2 in LTP‐allergic patients and their modulation during sublingual immunotherapy
por: Palomares, Francisca, et al.
Publicado: (2021)

Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab
por: Meoni, Gaia, et al.
Publicado: (2021)

In vitro effects of etanercept on the development of different T cell subsets in patients with juvenile idiopathic arthritis
por: Cimaz, Rolando, et al.
Publicado: (2011)

IL4I1 Is Expressed by Head–Neck Cancer-Derived Mesenchymal Stromal Cells and Contributes to Suppress T Cell Proliferation
por: Mazzoni, Alessio, et al.
Publicado: (2021)

SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron
por: Mazzoni, Alessio, et al.
Publicado: (2022)

Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients
por: Capone, Manuela, et al.
Publicado: (2016)

Fourth Dose of mRNA COVID-19 Vaccine Transiently Reactivates Spike-Specific Immunological Memory in People Living with HIV (PLWH)
por: Lamacchia, Giulia, et al.
Publicado: (2022)

SARS-CoV-2 infection and vaccination trigger long-lived B and CD4(+) T lymphocytes with implications for booster strategies
por: Mazzoni, Alessio, et al.
Publicado: (2022)

Phenotypic and functional features of human Th17 cells
por: Annunziato, Francesco, et al.
Publicado: (2007)

Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization
por: Lamacchia, Giulia, et al.
Publicado: (2022)

Th1-Induced CD106 Expression Mediates Leukocytes Adhesion on Synovial Fibroblasts from Juvenile Idiopathic Arthritis Patients
por: Maggi, Laura, et al.
Publicado: (2016)

Therapeutic Targets in Allergic Conjunctivitis
por: Labib, Bisant A., et al.
Publicado: (2022)

Perianal Crohn’s disease and hidradenitis suppurativa: a possible common immunological scenario
por: Giudici, Francesco, et al.
Publicado: (2015)

T Cell Response Toward Tissue-and Epidermal-Transglutaminases in Coeliac Disease Patients Developing Dermatitis Herpetiformis
por: Caproni, Marzia, et al.
Publicado: (2021)

The Therapeutic Potential of Targeting Cytokine Alarmins to Treat Allergic Airway Inflammation
por: Sy, Chandler B., et al.
Publicado: (2016)

Therapeutic Potential of Hematopoietic Prostaglandin D(2) Synthase in Allergic Inflammation
por: Rittchen, Sonja, et al.
Publicado: (2019)

Human interleukin 17–producing cells originate from a CD161(+)CD4(+) T cell precursor
por: Cosmi, Lorenzo, et al.
Publicado: (2008)

The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders
por: Jo-Watanabe, Airi, et al.
Publicado: (2019)

Novel therapeutic targets for allergic airway disease in children
por: Giallongo, Alessandro, et al.
Publicado: (2019)

Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study
por: Vultaggio, Alessandra, et al.
Publicado: (2020)

Hedgehog Signaling as a Therapeutic Target for Airway Remodeling and Inflammation in Allergic Asthma
por: Tam, Anthony, et al.
Publicado: (2022)

Platelet–Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma
por: Shah, Sajeel A., et al.
Publicado: (2017)

Prostacyclin Regulation of Allergic Inflammation
por: Patel, Kunj, et al.
Publicado: (2022)

IL33: Roles in Allergic Inflammation and Therapeutic Perspectives
por: Chan, Ben C. L., et al.
Publicado: (2019)

Immunological Targets of Biologic Drugs in Allergic Skin Diseases in Children
por: Di Filippo, Paola, et al.
Publicado: (2021)

Histamine-Releasing Factor, a New Therapeutic Target in Allergic Diseases
por: Kawakami, Yu, et al.
Publicado: (2019)

Rhinoviruses, allergic inflammation, and asthma
por: Gavala, Monica L., et al.
Publicado: (2011)

Neural Pathways in Allergic Inflammation
por: Mirotti, L., et al.
Publicado: (2010)

The Effects of Environmental Toxins on Allergic Inflammation
por: Yang, San-Nan, et al.
Publicado: (2014)

Inflammation as a Therapeutic Target in Atherosclerosis
por: Nguyen, Mau T, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r032r1101c4t98na2gpgvnbldm